Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.
Non-Profit Trusted Source of Non-Commercial Health Information
In exciting news, an international group of scientists have been using low frequency ultrasound bursts of microscopic bubble injections in tumor research, and this explosion is suggested to kill off the majority of the surrounding cancer cells. The noninvasive technology was developed to kill breast cancer cells, this is a promising innovation that, in theory, …
The Harvard University offshoot i20 Therapeutics is setting the goal of one day having those who suffer from diabetes to be able to treat it with pills rather than injections with a syringe when they need to take their medications. Bioengineering researchers began to publish their methods in 2018 for turning liquid medications into encapsulated …
Following publication in PNAS of a study describing the technology’s efficacy in mitigating obesity, heart failure, type 2 diabetes, and renal failure in mice, Wyss Institute for Biologically Inspired Engineering at Harvard University announced that Rejuvenate Bio has secured an exclusive worldwide licence from the university to commercialize a combination gene therapy technology developed to …
As reported by the NBC affiliate WREX, SwedishAmerican Hospital in Northern Illinois has opened the first ScriptCenter self serve pharmacy kiosk. The self service pharmacy kiosk opened in Rockford, Illinois on January 30, 2020, it is hospital based and open 24 hours a day for seven days a week; ScriptCenter is currently available for patients, …
Developing new drugs therapies can be very costly, one study estimated that pharmaceuticals can spend up to $3 billion or more over 12 years in research and development activities to gain clearance by the FDA to bring a new drug to market. An important part to any trial process is testing of toxicity and the …
As published in Nature Biomedical Engineering a device has been invented that can control neural circuits by using a tiny brain implant which can be managed by a smartphone, in a collaborative study from the Jeong group at KAIST, South Korea, and the Bruchas Lab in Seattle. According to the researchers this soft neural implant …
Opioids continue to be the drug of choice for chronic and surgical pain despite the side effects and risk for addiction. Use of opioids has led to a crisis and is fueling scientists to find alternative methods for pain management. Anesthetics that have prolonged duration from a single injection such as local anesthetics wear off …
Peptide therapeutics are being increasingly used due to their high potency, specific mode of action and safety; over 60 peptides are currently available, 140 are in clinical trials, and another 500 in preclinical development. Approximately 70% of peptides are delivered via injection, but due to needles not being very popular scientists are exploring alternative routes …
Grande Pharma miente puedes creer esto ? La familia propietaria del fabricante de OxyContin, Purdue Pharma, intentó reducir los peligros del analgésico opiáceo, sugiere documentos previamente no divulgados incluidos en un expediente judicial por el fiscal general de Massachusetts. La presentación incluye correos electrónicos y otras comunicaciones internas de Purdue que mencionan a la familia …
An inhalable form of a messenger RNA has been developed with engineers from MIT in which patients with lung disease may be able to find relief simply by breathing it in, as published in the journal Advanced Materials. Cells can be induced to produce therapeutic proteins with messenger RNA which hold great promise for …